Skip to main content
. 2015 Feb 20;137(5):1066–1075. doi: 10.1002/ijc.29467

Table 1.

Numbers of controls and cases by sex, age, histological subtype, history of IM and study

Controls N (%) All cases N (%) EBV+ve cases N (%) EBV‐ve cases N (%)
Total participants 347 503 155 348
Sex Female 144 (41) 225 (45) 49 (32) 176 (51)
Male 203 (59) 278 (55) 106 (68) 172 (49)
Age group (years) 15‐34 131 (38) 272 (54) 61 (39) 211 (61)
35‐49 81 (23) 99 (20) 31 (20) 68 (20)
≥50 135 (39) 132 (26) 63 (41) 69 (20)
Histological subtype Mixed cellularity 115 (23) 63 (41) 52 (15)
Nodular sclerosis 353 (70) 79 (51) 274 (79)
Other 35 (7) 13 (8) 22 (6)
Self‐reported IM Not recorded 12 201 70 131
No 316 (94) 268 (89) 72 (85) 196 (90)
Yes 19 (6) 34 (11) 13 (15) 21 (10)
Study SNEHD 320 (92) 283 (56) 82 (53) 201 (58)
YHHCCS 27 (8) 41 (8) 10 (6) 31 (9)
ITCH 0 (0) 179 (36) 63 (41) 116 (33)

All cases, all cHL cases; EBV+ve cases, EBV‐positive cHL cases; EBV‐ve cases, EBV‐negative cHL cases; N, number; IM, infectious mononucleosis; SNEHD, Scotland and Newcastle Epidemiological study of Hodgkin's Disease; YHHCCS, Young adult Hodgkin disease and Haematological malignancy Case Control Study; ITCH, Investigation of The Cause of Hodgkin lymphoma, a cHL case series.